Reglagene: Funding, Investors & Team (Oct 2026)
Reglagene primarily focuses on developing tubulin-based therapies for brain disorders. Drawing on its specialized knowledge in creating medications that can cross the blood-brain barrier, the company aims to revolutionize the treatment of brain diseases with innovative and safe therapies.
Reglagene has raised $770k across 2 funding rounds on record, the most recent an undisclosed round of $770k announced in May 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Reglagene Company Profile and Key Stats
Latest funding round on record: May 2024.
Reglagene Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Reglagene announced an undisclosed round in Aug 2023; the amount was not disclosed.
9 months later, an undisclosed round of $770k was announced in May 2024.
Reglagene Founders and Leadership Team
Contact details for the Reglagene team: 1 of 2 have an email address on file.
Start 14-day free trial →Reglagene Funding Compared to Other Biotechnology Startups
Reglagene's latest round of $770k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Reglagene in Biotechnology and Tucson
Companies Similar to Reglagene
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Reglagene Funding FAQs
What does Reglagene do?
Reglagene primarily focuses on developing tubulin-based therapies for brain disorders. Drawing on its specialized knowledge in creating medications that can cross the blood-brain barrier, the company aims to revolutionize the treatment of brain diseases with innovative and safe therapies.
How much funding has Reglagene raised?
Reglagene has raised $770k across 2 rounds on record. The most recent is an undisclosed round of $770k announced in May 2024.
When did Reglagene last raise funding?
Reglagene's most recent funding round on record is an undisclosed round of $770k, announced in May 2024.
Who founded Reglagene?
FundedIQ lists Helen Yeoman (Founder), Richard Austin (Founder) at Reglagene.
Where is Reglagene headquartered?
Reglagene is based in Tucson, Arizona, United States.
How many employees does Reglagene have?
Reglagene is in the 11-50 employee band.
How does Reglagene's funding compare to other Biotechnology startups?
Reglagene's latest round of $770k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Reglagene Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Reglagene is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.